The Food and Drug Administration’s teen anti-tobacco campaign prevented up to 587,000 young adults from smoking, according to a study. Research found that teens exposed to the campaign, The Real Cost, were less likely to pick up the habit. (MM&M)

Allergan and Endo have agreed to a $15 million settlement in an opioid lawsuit. The lawsuit, brought by two counties in Ohio, accused drugmakers and distributors of contributing to the opioid crisis. The trial was set to begin in October. (Reuters)

High-profile executives have departed Apple’s health team in recent months. Staffers said there is tension in the organization as some employees want to tackle bigger issues within healthcare while others are focused on tools for mostly healthy users. (CNBC)

An ousted Novartis scientist has denied wrongdoing in the Zolgensma data-manipulation scandal. Brian Kaspar, previously chief scientific officer of subsidiary AveXis, was let go shortly after the data scandal became public. His attorney said he has not been involved with the company since May. (CNBC)

Teva has launched a generic EpiPen for young children for $300 a pack. The drugmaker already has an EpiPen generic on the market for adults. Analysts said Teva could make about $300 million in annual sales from the generics. (Reuters)